SURGICAL TREATMENT OF PULMONARY ASPERGILLOMA Adalet Demir, Mehmet Zeki Günlüoğlu, Akif
Download ReportTranscript SURGICAL TREATMENT OF PULMONARY ASPERGILLOMA Adalet Demir, Mehmet Zeki Günlüoğlu, Akif
SURGICAL TREATMENT OF PULMONARY ASPERGILLOMA Adalet Demir, Mehmet Zeki Günlüoğlu, Akif Turna, Hasan Volkan Kara, Seyyid İbrahim Dinçer Yedikule Teaching Hospital for Chest Diseases and Thoracic Surgery, Department of Thoracic Surgery, Istanbul, TURKEY. 1 Aspergilloma generally results from colonization of an existing lung cavity (tuberculosis, bronchiectasis, lung abcess, bulla, tumor cavity, sarcoidosis) by Aspergillus fumigatus, the most common saprophytic species of Aspergillus in human disease, producing a fungus ball or a mycetoma The most common symptoms are; cough, sputum and hemoptysis. Hemoptysis 55-91% Massive hemoptsis 10-25% 26% of all aspergilloma patients dies as massive hemoptysis. Major hemoptysis rate of asymptomatic patients is 20% Treatment Surgery Resection (Lobectomy, Segmentectomy, Wedge resection, Pneumonectomy, pleuropneumonectomy) Cavernostomy Cavernostomy+myoplasty Embolisation İntracavitary or endobronchial antifungal therapy Sistemic antifungal therapy Radiation therapy Medical treatment Some antifungal agents (itraconasole) are not effective because of intracavitary fibrosis Study 1988 - 2003 41 patients 5 female, 36 male Mean age: 42(17-70)years. All patients underwent posteroanterior and lateral chest radiography, computed tomography of the chest, and fiberoptic bronchoscopy. Transthoracic fine-needle aspiration biopsy was performed in some patients who could not be diagnosed by other means. All patients operated on independent of symptoms Surgical approach is posterolateral thoracotomy. Degree of hemoptysis in 24 h >300cc=massive Prolonged air leak>7 days Operative mortality: in 30 days or along hospitalisation 34 patients have preoperative diagnosis of Aspergilloma, 7 patients have not The most common symptom is hemoptysis (75%). Massive hemoptysis 7% Left upper lobe 51% (21), right upper lobe 39% (16), right lower lobe 10% (4) Pneumonectomy 5 patients 1 completion pneumonectomy because of recurrent hemoptysis in patients performed lobectomy 2 patients with cavitary lesions in both lobes 1 patient with destroyed lung 1 patient because of technical difficulties Morbidity and Mortality Postoperative morbidity rate 24.3% 16 complication in 10 patients Mortality rate 2.4% (1 patient) performed pneumonectomy, developed BPF, died in 48th hour because of respiratory insufficiency Follow up Mean follow up time 67 months (11-192) Recurrent hemoptysis rate: 2,4% (1 patient) performed completion pneumonectomy One patient died as respiratory insufficiency at 40th month Conclusion Surgical resection for aspergilloma offers potential benefits with low morbidity and mortality, prevention of massive hemoptysis, eradication of the pyogenic component, and limitation of the symptoms. However, pneumonectomy must be avoided if possible as it leads to increased morbidity.